The pharmaceutical industry constantly seeks robust and reliable chemical intermediates to streamline the synthesis of Active Pharmaceutical Ingredients (APIs). Among these, 3-(1-Piperazinyl)-1,2-benzisothiazole (CAS 87691-87-0) stands out as a critical component, particularly noted for its role in the production of antipsychotic medications such as Ziprasidone and other complex molecules. As a leading manufacturer and supplier of this fine chemical, we understand the intricate demands of API synthesis.

The versatility of 3-(1-Piperazinyl)-1,2-benzisothiazole lies in its chemical structure, featuring a benzisothiazole core fused with a piperazine ring. This unique combination makes it an excellent starting material or intermediate for reactions that build more complex drug molecules. Its reliable availability from trusted manufacturers is essential for research chemists and production teams looking to develop new therapeutic agents or optimize existing processes. When you buy this compound, understanding its synthesis pathways and potential downstream applications is crucial for R&D scientists.

The synthesis of Ruracidone, for example, prominently features 3-(1-Piperazinyl)-1,2-benzisothiazole as a key precursor. The quality and purity of this intermediate directly impact the yield and final purity of the API, underscoring the need for high-grade materials. Procurement managers often look for suppliers in China who can consistently deliver material meeting precise specifications, such as a white powder appearance and purity levels of 98% or higher. This ensures compliance with pharmaceutical regulations and contributes to the overall safety and efficacy of the finished drug product.

For companies seeking to purchase 3-(1-Piperazinyl)-1,2-benzisothiazole, working with an established manufacturer offers distinct advantages. Beyond competitive pricing, direct sourcing ensures better control over the supply chain, quality assurance, and timely delivery. Our expertise in fine chemical manufacturing allows us to support your projects from early-stage research to full-scale production. We are committed to providing the pharmaceutical industry with the high-quality intermediates necessary for groundbreaking drug development, making us a preferred supplier for critical chemical building blocks.